These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10635910)

  • 1. [Anti-vimentin antibody].
    Kondo H
    Nihon Rinsho; 1999 Nov; 57 Suppl():553-6. PubMed ID: 10635910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological tests: Anti-vimentin antibodies].
    Kondo H; Sakai M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():646-9. PubMed ID: 16111358
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of anti-vimentin antibody assay].
    Nakamura Y; Takahashi T; Niwa A
    Nihon Rinsho; 1990 Feb; 48 Suppl():509-12. PubMed ID: 2192144
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
    Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
    Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
    Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
    J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.
    Damjanovska L; Thabet MM; Levarth EW; Stoeken-Rijsbergen G; van der Voort EI; Toes RE; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2010 Apr; 69(4):730-2. PubMed ID: 19451136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical significance of antibodies to vimentin intermediate filaments in patients with rheumatoid arthritis].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1987 Oct; 27(5):356-63. PubMed ID: 3331496
    [No Abstract]   [Full Text] [Related]  

  • 10. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.
    Tilleman K; Van Steendam K; Cantaert T; De Keyser F; Elewaut D; Deforce D
    Rheumatology (Oxford); 2008 May; 47(5):597-604. PubMed ID: 18326534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
    Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
    Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [immunological and serological tests for diagnosis of rheumatoid arthritis: antinuclear antibodies].
    Hirakata M; Kaneko Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():333-40. PubMed ID: 15799373
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheumatoid arthritis-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, anti-FRP antibodies)].
    Kubota T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():488-90. PubMed ID: 20942110
    [No Abstract]   [Full Text] [Related]  

  • 15. Human vimentin autoantibodies preferentially interact with a peptide of 30kD mol. wt, located close to the amino-terminal of the molecule.
    Alcover A; Hernández C; Avila J
    Clin Exp Immunol; 1985 Jul; 61(1):24-30. PubMed ID: 3899428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the proteins associated with Sa antigen].
    Chen H; Yao ZJ; Tang FL
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1896-900. PubMed ID: 17064527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
    Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a simple and quantitative immunospot assay for detecting anti-type II collagen antibody using an infrared fluorescence imaging system (IFIS).
    Ota S; Kanazawa S; Kobayashi M; Otsuka T; Okamoto T
    J Immunol Methods; 2005 Apr; 299(1-2):189-98. PubMed ID: 15914201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.